Abstract:BACKGROUND:The ability of a transcription factor to regulate its targets is modulated by a variety of genetic and epigenetic mechanisms. Alternative splicing can modulate gene function by adding or removing certain protein domains, and therefore affect the activity of protein. Reverse engineering of gene regulatory networks using gene expression profiles has proven valuable in dissecting the logical relationships among multiple proteins during the transcriptional regulation. However, it is unclear whether alternative splicing of certain proteins affects the activity of other transcription factors.RESULTS:In order to investigate the roles of alternative splicing during transcriptional regulation, we constructed a statistical model to infer whether the alternative splicing events of modulator proteins can affect the ability of key transcription factors in regulating the expression levels of their transcriptional targets. We tested our strategy in KIRC (Kidney Renal Clear Cell Carcinoma) using the RNA-seq data downloaded from TCGA (the Cancer Genomic Atlas). We identified 828of modulation relationships between the splicing levels of modulator proteins and activity levels of transcription factors. For instance, we found that the activity levels of GR (glucocorticoid receptor) protein, a key transcription factor in kidney, can be influenced by the splicing status of multiple proteins, including TP53, MDM2 (mouse double minute 2 homolog), RBM14 (RNA-binding protein 14) and SLK (STE20 like kinase). The influenced GR-targets are enriched by key cancer-related pathways, including p53 signaling pathway, TR/RXR activation, CAR/RXR activation, G1/S checkpoint regulation pathway, and G2/M DNA damage checkpoint regulation pathway.CONCLUSIONS:Our analysis suggests, for the first time, that exon inclusion levels of certain regulatory proteins can affect the activities of many transcription factors. Such analysis can potentially unravel a novel mechanism of how splicing variation influences the cellular function and provide important insights for how dysregulation of splicing outcome can lead to various diseases.

Epigenetic Control of Adaptive or Homeostatic Splicing of Alternative Exons and Gene Expression During Interval-Training Activities of Pituitary Cells

Epigenetic control of adaptive or homeostatic splicing during interval-training activities

Roles of Alternative Splicing in Modulating Transcriptional Regulation

Epigenetic Regulation of Alternative Splicing.

SIRT1 Involved in the Regulation of Alternative Splicing Affects the DNA Damage Response in Neural Stem Cells.

Alternative splicing of HDAC7 regulates its interaction with 14-3-3 proteins to alter histone marks and target gene expression

Peroxisome Proliferator-activated Receptor γ Coactivator-1 α Isoforms Selectively Regulate Multiple Splicing Events on Target Genes

Rethinking gene regulatory networks in light of alternative splicing, intrinsically disordered protein domains, and post-translational modifications

Alternative Splicing As a Biomarker and Potential Target for Drug Discovery

Mechanisms of Neuronal Alternative Splicing and Strategies for Therapeutic Interventions

Splicing activates transcription from weak promoters upstream of alternative exons

Mechanism of Alternative Splicing and Its Regulation.

Alternative splicing links histone modifications to stem cell fate decision

Precise Temporal Regulation of Alternative Splicing During Neural Development.

Specific histone modifications associate with alternative exon selection during mammalian development

A neural alternative splicing program controls cellular function and growth in Pancreatic Neuroendocrine tumours

Coordinated alternative splicing decisions via stepwise exon definition

Control of alternative splicing by forskolin through hnRNP K during neuronal differentiation

Mechano-Regulation of Alternative Splicing

Cell-Type-Specific Alternative Splicing Governs Cell Fate in the Developing Cerebral Cortex

Regulation of alternative splicing and polyadenylation in neurons